Reactive skin decontamination lotion (RSDL) is a proposed replacement for the existing skin and equipment decontamination kit. Because RSDL may need to be used to decontaminate wounded personnel. we conducted an assessment of the effect of this agent on wound healing. A skin incision model using male Sprague Dawley rats (n 19 rats/group) was used. A 7.0-cm incision was made through the skin, and RSDL was (experimental group) or was not (control group) applied to the open wound: the wound edges were then approximated with sutures. Seven days later. animals were euthanized and wound sam~les were taken. Healing was assessed by measuring mechamcal strength. collagen content, and histological appearance. RSDL-treated wounds had 23% lower tensile strength 
Introduction

P
reparation for chemical attack occupies an important place in current military medical doctrine. The readiness of U.S. forc.es ~~ v.,;thstand a chemical attack depends on the ready a\'atlabihty of chemical decontamination kits for personnel and equipment. Reactive skin decontamination lotion (RSDL) (E· Z-E:' v1. Lake Success. New York) is a Food and Drug Administration-approved medical device (K023969) that is the proposed replacement for the current M-291 skin decontamination kit. It is for use by indhiduals to remove and to neutralize chemical wariare agents from the skin immediately after exposure. RSDL is a yellow liquid with the consistency of transmission fluid, packaged in a single use soft pack with an foam pad applicator. 1 The Food and Drug Administration has approved RSDL as a novel chemical decontaminating agent for use on intact ~ki n. This agent has ~hown improved efficacy, compared with the M-291 kit: however. the effect of the current formulation on wound healing is unknown. Pre\ious formulations have had adverse tissue effects on wounded skin in animal models. 2 Because many chemical casualties may sustain soft tissue inJuries as well, the effect (if any) of RSDL on wou nd healing must be inrestigated before fielding.
The purpose of this study was to determine the impact of RSDL on the healing process in wounded skin after direct application of the agent to a standardized animal wound. The rat skin incision model was chosen because of its long history of use in tissue injury and wound-healing studies.~ Ou r primary outcome measure of wound healing was a biomechanicaJ properly, namely. wound breaking strength at 7 days. Our hypothesis was lhal there would be no difference in wound breaking strength at 7 days between RSDL-treated and untreated wounds. Secondary endpoints included measures of wound collagen content and microscopic analysis.
Methods
Th: entire protocol was conducted under good laboratory practices. RSDL was obtained from the manufacturer. All animal yrocedures ~d protocols were approved by the U.S. Army Institute of Surgtcal Research institutional animal care and use committee. Animals were housed and cared for in accordance with the Guide to the Care and Use of Laboratory Animals. in a vivarium accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care. Animals were provided \vilh food and water ad libitum before and after all procedures. All procedures were performed under anesthesia with 1.5 to 2.5% isoflurane in oxygen. administered ria a nosecone and adjusted to maintain a surgical plane. PostproceduraJ pain was controlled with buprenorphine (0.1 m~/kg. administered throu~h intraperito~eal injection). Male Sprague Dawley rats (age. 90-120 days: wetghl. 250-350 g) were obtained from Harlan (Indianapolis. Indiana).
The don;um of the anesthetized animals was shaved \vith an electric clipper. and the are1 was \viped \vith 70% isopropanol and draped in aseptic fashion. A template was used to mark the proximal and distal portions of the incision and the locations of st.ttures (Fig. lA) . The ends of the incision area were grasped \\11th forceps. and the incision was made in the dorsal midli ne. beginning cranially 4.0 em from the skull base and extending 7.0 em (Fig. I . Band C) . ln treatment group animals, 0.25 mL of RSDL was applied directly into the surgical wound with a sterile pipette. Simple interrupted 4 0 monofilament nylon sutures were placed 0.5 em from the skin edge, beginning 0.5 em from the end of the incision. for closure (Fig. I D) . For RSDL treated animals. closure wa~ perfonned over the pooled agent (Fi~. I E).
After closure of the incision. animals were allowed to recover from anesthesia and were monitored until they exhibited nom1al behavior. They were then returned to their cages: thev were we!ghed daily and assessed t\vice daily for 7 days. Anesthetized antmals were euthanized \\ith an intracardiac injection of sodium pentobarbital (150 mg/kg) on postoperative dav 7. After euthanasia. sutures were carefully cut and remo\'ed. The entire wound area was sharply excised in full thickness. \\ith a 2 em margin around the entire wound. All underlying connective lissue. fascia, and adipose tissue were removed. The specimen was sectioned transversely into ~L\ 0.8 em wide pieces by using a standard block with imbedded blades. The distribution of tissue
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Public reporting burden for the collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to a penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. samples from head to tail is shown in (Fig. 2) . Duplicate pieces were (l) analyzed for tensile stren~. (2) snap-frozen and used for an assay of tissue collagen (a marker of healing). and (3) fixed in formalin and sectioned for histological analysts. The tensile strength of the wound was tested by using a materials testin~ system (model LRX Plus. Lloyd Instruments, Farehan1. Hampshire. United Kin~dom) with a 50-N load cell (Fig. 3) . Both ends of the specimen were clamped In the device. with the direction of tensioning perpendicular to the wound. A preload of 0.5 N was placed on the specimen (Fig. 4A) . and a calibrated image of the specimen was captured by using a digital camera (Cool pix 995. Nikon. Tokyo. Japan) mounted on the lest platform. This image was later used to determine the width of the sample. which was used to normalize wound breaking strength. The specimen was then stretched to its breakpoint at a rate of 200 mm/s (Fig. 48) .
Collagen content was measured with a modified version of the technique described by Reddy and Enwemeka. 8 weighed, homogenized in 2 N NaOH. and stored at -80 C until processing. Concentrated HCI was added to the samples (nlll in triplicate). controls. and standards. and samples were autoclaved for hydrolysis. Chloramine-T reagent was added. followed by Ehrlich's reagent. resulting in colorimetric changes propor tiona! to the hydroxyproline content in the samples. Absorbance at 545 nm was measured. and hydro:\:yproline content was calculated by using a standard cur.·e.
Tissue sections for histological analysis were stained with hematoxylin <md eosin. All samples were graded by a boardcertified veterinary pathologist. who was blinded to the sample group. The following parameters were detennined for each slide: ( l) ~ap width (reported as mean ± SO: all other values are reported as medians with ranges). (2) collagen density (I = sparse; 2 same as surrounding dermis; 3 more than surrounding dermis). (3) collagen bundle orientation (0 cannot determine; l perpendicular to skin surface; 2 = parallel to skin surface). (4) collagen polarization (0 cannot determine; 1 -parallel arrays; 2 basketweave pattern). (5) cellularity (quantity of endothelial and connective tissue cells) tn the incision (I sparse; 2 -same as surrounding dermis: 3 more than surrounding dermis). (6) epithelialization (l -partial; 2 -complete). and (7) inflammation (0 undetectable; 1 = minimal; 2 mild).
A power analysis was performed before the experiment, assumin~ that the diiTerencc between the mean breaking strength values for the control and treatment groups was < 1 OOtb. with a common within-group SD of 100/o. The number of animals required was 19 per group to achieve 800/o power to show that the mean breaking strength for the treatment group was the same as (neither lower nor higher than) that for the control ~roup. with a set at 0.05. Therefore. 38 animals were randomly assigned to eilher the treatment group or the control group. Data from duplicate samples for each outcome measure were averaged. Continuous data were compared by using Student's onetailed I test and are reported as group mean SO. Ordinal data were analyzed by usin~ the Mann-Whitney rank sum test and are reported as median and ran~e. Statistical significance was attributed to p 0.05.
Results
The RSDL-treated wounds had significantly less tensile strength than did control wounds. RSDL application resulted in a wound tensile strength of 6.0 " 1.3 N/cm 2 • compared with 7.8 + 1.9 N/cm 2 for the control wounds (p 0.0023). RSDL treatment also resulted in significantly lower collagen content. compared with control wounds. The RSDL group had 67.0 6. 7 g of colla~en per 100 g of wet tissue. whereas the control group had 75.3 + 10.5 g per 100 g (p 0.0164). Despite the biomechanical and biochemical evidence of impaired wound healing. histopathological analysis failed to reveal any signlfi cant diiTerences between RSDlrtreated wounds and control wounds (Table 1) .
Discussion
The results of this study demonstrated a small but statistically si~nificant reduction in the tensile stren~th of RSDLtreated. suture-closed wounds. compared \vith that of untreated closed wounds. This finding was corroborated by the significantly lower concentration of collagen within the wounds of treated animals. Results of quantitative histological analysis of gap \vidth were not si~nificantly different between the groups; semiquantitative histological assessments were also not significantly different between groups. These are important observa Uons because they suggest that. despite the statistically significant diiTerences in tensile strength and collagen content, the clinical significance of these diiTerences is undetermined In this model.
Previous formulations of RSDL caused si~nificant damage to intact sktn and significantly hindered wound healing. 2 By comparison. we found the current formulation to have only a small impact on wound healing and no observable impact on intact sktn. based on gross visual assessment. The latter point is based on the fact that. during application. a volume of RSDL leaked from the wound upon closure. We made no attempt to remove this excess. and It remained on the skin until the end of Effects of RSDL on Wound Healing the experiment. Based on our nonsystematic observations. there was no damage to the intact skin in contact with the a.~ent.
Our model is limited bv the lack of available data with which to determine the biological si~nificance and direct tissue effects of wound exposure to RSDL. although secondary evidence Is present in the form of histological equivalence between the RSD!Areated and control groups. The current model involves a situation in which RSDL was applied in excess. saturating the wound. Furthem1ore. the agent was sealed within the wound by suturing the skin closed over it. In an actual clinical scenario. it is likely that at least excess RSDL would be removed from the wound via irrigation and tissue debridement. which is the stan dard of care for all battlefield wounds. 9 Additionally, prinmry closure of most war wounds is contraindicated because of high rates of Infection. RSDL application had the effect of reducing both the tensile strength of the healing wound and the collagen content. These effects may be ma~nified in the scenario of devitalized contaminated tissue in many combat wounds. The current study examined a single time point early in the healing process. It cannot be determined from these data whether RSDL reduces the extent of healing at later time points. Characteril.a tion of chronic healing and scarring would require examination at later stages of wound healing.
Conclusions
Application of RSDL directly into an open surgical wound, followed by primary closure, resulted in decreased wound ten sile strength and collagen content at 7 days. There were no differences noted in the histological appearance ofRSDL-treated wounds. In this animal model. RSDL application had a ne~alive 321 Impact on wound healing: this may have clinical Implications for the treatment and outcomes of chemical casualty combat trauma.
